Advisory Team
Dr. Steven Dow is a veterinary internist and immunologist in the College of Veterinary Medicine at Colorado State University who directs a research program developing new immunotherapeutic approaches to the treatment of cancer and infectious diseases.
In the infectious disease program, his laboratory has pioneered the use of immune-activated mesenchymal stromal cells for treatment of chronic, drug-resistant infections in companion animals and horses. His laboratory also collaborates with investigators in the Translational Medicine Institute to develop new immune-based approaches to management of musculoskeletal injuries and wound healing.
Dr. Koenig is a tenured Associate Professor in the Department of Clinical Studies, Ontario Veterinary College, and University of Guelph, Canada. She is the Head of the Large Animal Clinic at the Ontario veterinary College Health Science Center.
Dr. Koenig’s main area of research is in tissue regeneration and healing, with emphasis on wound and tendon healing in horses. Investigation of different modalities for tissue regeneration and wound healing, such as allogeneic cord blood stem cells, low level light lasers and shock wave treatment.
These modalities accelerate the healing process through interacting with different cellular pathways. Research has been done to investigate the effect of low level light lasers and shock waves on wound healing in horses. Also, the anti-inflammatory properties of allogeneic cord blood stem cells on induced synovitis in horses have been demonstrated. The effect of repeated administration of stem cells in the treatment of superficial digital flexor tendinitis is currently evaluated. Another current area of research is the effect of shockwave application on stem cells.
Dr. Koenig is a very active research team member as a clinician and surgeon. As clinician she usually design and participate in the in vivo trials, either using animal models or clinical cases.
Dr. Pezzanite is a veterinary surgeon and Assistant Professor in the Department of Clinical Sciences within the College of Veterinary Medicine at Colorado State University. She attended veterinary school at Cornell University and completed her residency and PhD training at Colorado State University through the Center for Immune and Regenerative Medicine and Orthopaedic Research Center within the Translational Medicine Institute.
Dr. Pezzanite’s research focuses on musculoskeletal injuries and trauma, including novel regenerative immunotherapies to treat septic arthritis and osteoarthritis. Her specific research interests are traumatology and regenerative therapeutic approaches to improve tissue healing and athletic outcomes in equine orthopedic surgery with translational relevance to human patients.
She is a member of the NIH NCATS Colorado Clinical and Translational Sciences Institute (CCTSI), American College of Veterinary Surgeons, Veterinary Orthopedic Society, American Association of Equine Practitioners and AOVet Foundation. Her research has been funded by NIH/NCATS TL1 and T32 grants, AAEP Past President’s Award, Grayson Jockey Club Stormcat Career Development Award and Colorado State University Distinguished Professors Award.
Dr. Goodrich is a translational scientist whose research focuses on regenerative medicine, gene therapies, and biologics to improve joint and bone repair in both animals and humans. She is, concurrently, an equine surgeon specializing in ortho-pedic surgery and lameness with a focus on musculoskeletal injuries and trauma,
Dr. Goodrich is Director of the Orthopaedic Research Center at Colorado State University’s C. Wayne McIlwraith Translational Medicine Institute, a Founding Fellow in Minimally Invasive Surgery at the American College of Veterinary Surgeons, Chair of American College of Veterinary Surgeons (ACVS), a member of the Board of Directors for North American Veterinary Regenerative Medicine Association (NARVMA), and was a co-founder of, and is the immediate past Chair for, the Preclinical Models Section of the Orthopedic Research Society.
Dr. Goodrich has received the Elastikon Award in Research Excellence from the Grayson Jockey Club Research Foundation, the Cabaud Award in Research from American Orthopaedic Society of Sports Medicine, and CSU’s American Association of Equine Practitioners Clinician of the Year Award for teaching excellence. She earned her MSc in pharmacology at Marion DuPont Equine Medical Center and PhD in cellular and molecular biology of cartilage repair at Cornell College of Veterinary Medicine where she served as faculty surgeon.
Dr. Alan Manning, MSc, DVM
Advisor, Equine Sports Medicine
A native of Prince Edward Island, Dr. Manning grew up immersed in the horse environment, competing on the “A” jumper circuit and involved in the standardbred industry. Prior to becoming a Veterinarian he pursued a Masters in equine reproduction at the Western College of Vet Medicine, Saskatoon.
Following graduation from OVC in 1990 he was in private practice for 8 years after which he left to set up his own clinic in the Erin area on a 100 acre farm, where today he also breeds & develops young warmbloods. Alan continues to be active in the reproduction aspect of veterinary medicine, in particular, frozen semen work at the clinic.
The emphasis of his time is spent on equine sports medicine, particularly lameness and performance horse issues and is always keen to incorporate new technologies & treatments into the practice such as biological therapies for joint and tendon/ligament injuries, stem cell implantation, ultrasound guided injections, shock wave and laser therapies.
A passion for equine lameness has led Alan to become one of only ten equine veterinarians in Canada belonging to ISELP (International Society of Equine Locomotor Pathology) dedicated specifically to advanced education in the field of equine lameness, including the latest developments in diagnostic imaging of bones, joints, tendons and muscles, as well as treatments,
To complement the practice Alan has become one of the few veterinarians in Canada with FEI designation status, most recently attending the Pan Am Games in October 2011 as the team veterinarian for the Canadian Dressage Team.
Dr. Roges is an internationally-experienced MD and Senior Manager with more than 15 years of management expertise in drug development and clinical research for pharmaceutical companies and contract research organizations.
He was a Country Manager and Director of Operations for YM BioSciences Inc., a public company on TSX, NYSE (acquired by Gilead Inc., Canadian subsidiary) for 14 years. He has also been a Regional Research Director with Syreon Corporation, Manager of Clinical Research Services with Regxia Inc. and Senior Clinical Project Manager with Forbius Inc. (acquired by Pfizer).
He is currently Managing Director – Science and Medicine – with Cresswell Advisors Inc. a consulting firm providing assistance and direction to development-stage companies in the life sciences.
His previous experience of 18 years as a scientist and lecturer in Life Sciences is also recognized.
